−0.055HKD
−231.34 MHKD
96.31 MHKD
1.68 B
About MABPHARM LTD
Sector
CEO
Hao Wang
Website
Headquarters
Hong Kong
Employees (FY)
347
Founded
2015
ISIN
KYG5780F1046
FIGI
BBG00P5G4RJ9
Mabpharm Ltd. engages in the research, development, and manufacture of monoclonal antibody drugs for the treatment of cancer and autoimmune diseases. The company was founded on June 1, 2018 and is headquartered in Hong Kong.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 2181 is 0.425 HKD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange MABPHARM LTD stocks are traded under the ticker 2181.
MABPHARM LTD is going to release the next earnings report on Aug 23, 2024. Keep track of upcoming events with our Earnings Calendar.
2181 stock is 2.41% volatile and has beta coefficient of 2.01. Check out the list of the most volatile stocks — is MABPHARM LTD there?
Yes, you can track MABPHARM LTD financials in yearly and quarterly reports right on TradingView.
2181 stock has fallen by 5.56% compared to the previous week, the month change is a 15.00% fall, over the last year MABPHARM LTD has showed a 55.73% decrease.
2181 net income for the last quarter is −118.14 M HKD, while the quarter before that showed −113.09 M HKD of net income which accounts for −4.46% change. Track more MABPHARM LTD financial stats to get the full picture.
Today MABPHARM LTD has the market capitalization of 1.75 B, it has decreased by 2.08% over the last week.
No, 2181 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 2181 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MABPHARM LTD stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 347.00 employees. See our rating of the largest employees — is MABPHARM LTD on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MABPHARM LTD technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MABPHARM LTD stock shows the sell signal. See more of MABPHARM LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MABPHARM LTD EBITDA is −155.63 M HKD, and current EBITDA margin is −161.61%. See more stats in MABPHARM LTD financial statements.